Literature DB >> 3445816

Mechanism of the congestion of lymph nodes induced by ellagic acid in rats.

J Damas1, G Remacle-Volon, A Adam.   

Abstract

Intravenous injection of ellagic acid (EA, 30 mg/Kg), an activator of the Hageman factor, induced congestion of lymph nodes and dilatation of the spleen in rats. The dilatation of the spleen was inhibited by heparin, thrombin, defibrase, clocoumarol, lambda carrageenan, SBTI, PCR 4099 and CCI 17810. The congestion of lymph nodes was inhibited by heparin, thrombin, defibrase, clocoumarol, SBTI, lambda carrageenan, aspirin, indomethacin and ketoprofen, phentolamine and hexamethonium. Thrombin, defibrase, lambda carrageenan did not induce any congestion of the lymphoid tissues. These results suggest the the dilatation of the spleen induced by ellagic acid would result from blood coagulation, platelet stimulation and kinin formation. The congestion of lymph nodes would depend on kinins, blood coagulation and prostaglandin;s. The activation of Hageman factor in acute inflammatory reactions could mediate the early congestion of lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3445816     DOI: 10.1007/BF02009047

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  19 in total

1.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

2.  Effects of bradykinin on rat lymphocytes.

Authors:  J Stachurska; W Roszkowski; M Kopeć; J Ryzewski
Journal:  Proc Soc Exp Biol Med       Date:  1976-12

3.  [Kinin formation in vivo after administration of dextran sulfate in rats].

Authors:  J Lecomte; J Damas
Journal:  C R Seances Soc Biol Fil       Date:  1969-05

4.  Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction.

Authors:  D G McKay; G Müller-Berghaus; V Cruse
Journal:  Am J Pathol       Date:  1969-03       Impact factor: 4.307

5.  Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance.

Authors:  H J Schwartz; R W Kellermeyer
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

Review 6.  The biochemistry and pathophysiology of the contact system of plasma.

Authors:  C G Cochrane; J H Griffin
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

Review 7.  Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation.

Authors:  A P Kaplan; M Silverberg; J T Dunn; B Ghebrehiwet
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

8.  Studies on the vascular and hematological changes induced by ellagic acid in rats.

Authors:  J Damas; A Adam; G Remacle-Volon; V Grek
Journal:  Agents Actions       Date:  1987-12

9.  Inhibition of the thrombocytopenic effect of exogenous and endogenous thrombin by PCR 4099 (d,1)methyl 2-(2-chlorophenyl)-2(4,5,6, 7-tetrahydrothieno (3,2-c)pyridin-5-yl) acetate.hydrochloride.monohydrate.

Authors:  J Damas; V Grek; G Remacle-Volon
Journal:  Thromb Res       Date:  1987-12-01       Impact factor: 3.944

10.  Enhancement of the permeability-increasing effect of bradykinin and substance P by a peptide derived from fibrinogen.

Authors:  M Eriksson; B Gerdin; T Saldeen
Journal:  Int J Microcirc Clin Exp       Date:  1983
View more
  2 in total

1.  Studies on the vascular and hematological changes induced by ellagic acid in rats.

Authors:  J Damas; A Adam; G Remacle-Volon; V Grek
Journal:  Agents Actions       Date:  1987-12

2.  Disorders in Blood Circulation As a Probable Cause of Death in Dogs Infected with Babesia Canis.

Authors:  Wojciech Zygner; Anna Rodo; Olga Gójska-Zygner; Paweł Górski; Justyna Bartosik; Grzegorz Kotomski
Journal:  J Vet Res       Date:  2021-07-05       Impact factor: 1.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.